Drug Detail:Trospium (Trospium [ tros-pee-um ])
Drug Class: Urinary antispasmodics
Usual Adult Dose for Urinary Incontinence
Immediate-release formulation:
20 mg orally 2 times a day
Extended-release formulation:
60 mg orally once a day in the morning
Use: for overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency
Usual Adult Dose for Urinary Frequency
Immediate-release formulation:
20 mg orally 2 times a day
Extended-release formulation:
60 mg orally once a day in the morning
Use: for overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency
Usual Geriatric Dose for Urinary Incontinence
Immediate-release formulation:
75 years and older:
20 mg orally once a day based on tolerability
Extended-release formulation:
60 mg orally once a day in the morning
Use: for overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency
Usual Geriatric Dose for Urinary Frequency
Immediate-release formulation:
75 years and older:
20 mg orally once a day based on tolerability
Extended-release formulation:
60 mg orally once a day in the morning
Use: for overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency
Renal Dose Adjustments
Immediate-release formulation:
- Mild to moderate renal impairment (CrCl 30 to less than 90 mL/min): No adjustment recommended.
- Severe renal impairment (CrCl less than 30 mL/min): 20 mg orally once a day at bedtime
Extended-release formulation:
- Mild to moderate renal impairment (CrCl 30 to less than 90 mL/min): No adjustment recommended.
- Severe renal impairment (CrCl less than 30 mL/min): Not recommended.
Liver Dose Adjustments
Immediate-release formulation:
- Mild to moderate hepatic impairment: No adjustment recommended.
- Severe hepatic impairment: Caution recommended.
Extended-release formulation:
- Mild hepatic impairment: No adjustment recommended.
- Moderate to severe hepatic impairment: Caution recommended.
Precautions
CONTRAINDICATIONS:
- Hypersensitivity to the active component or any of the ingredients (e.g., angioedema, rash, anaphylactic reaction)
- Urinary retention
- Gastric retention
- Uncontrolled narrow-angle glaucoma
Safety and efficacy have not been established in patients younger than 18 years.
Consult WARNINGS section for additional precautions.
Dialysis
Data not available
Other Comments
Administration advice:
- This drug should be given 1 hour before meals or on an empty stomach.
- This drug should be taken with water.
Storage requirements:
- Store at 20C to 25C (68F to 77F); excursions permitted to 15C to 30C (59F to 86F).
- Protect from light.
Patient advice:
- Do not drive or operate machinery until you know how this drug affects you.
